Original Article

Effect of Eicosapentaenoic Acid on the Expression of ABCG1 Gene in the Human Monocyte THP-1 Cells

Abstract

Cardiovascular disease (CVD) is the leading cause of death and disability in developed countries. Atherosclerosis is the major cause of CVD, accounting for about half of the attributed deaths. Cholesterol homeostasis is one of the most important factors in atherosclerosis. ATP-Binding cassette transporters cholesterol. Omega (ω) 3 fatty acids are important ligands for regulation of ABC transporters such as ABCG1. Concern has been raised that the low absolute intakes of EPA and high ratios of ω-6 polyunsaturated fatty acids (ω-6 PUFA) to EPA may predispose some individuals to CVD. Eicosapentaenoic acid (EPA) is the most abundant ω3 fatty acid in the diet. The objective of this study was to evaluate the effect of different concentrations of EPA on the expression of ABCG1 gene in the human monocyte THP-1 cells. In this study, THP-1 cells were cultured in RPMI 1640 medium, THP-1 monocytes were then differentiated to macrophages with PMA (phorbol myristic acid) and stimulated with 50, 75 and 100 μM of EPA for 24 h at 37°C. We examined the effects of EPA treatment on the expression of ABCG1 gene using Quantitative Real time RT-PCR (qRT-PCR). Our results, indicate that ABCG1 mRNA expression was significantly reduced by 50, 75 and 100 μM EPA fatty acid treatments as compared to the control cells (р = 0.009, р < 0.001 and р = 0.002, respectively). These results suggest that polyunsaturated fatty acids (PUFAs) such as EPA have an effect on the cholesterol homeostasis in macrophages, and they can change the expression of ABCG1 gene. It seems that EPA has different effects on gene expression and lipid metabolism.

Kreger BE, Odell PM, D'Agostino RB, et al. Long-term intra-individual cholesterol variability:natural course and adverse impact on morbidity and mortality:the Framingham Study. Am Heart J 1994;127(6):1607-14.

Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257(16):2176-80.

Kannel WB, Giordano M. Long-term cardiovascular risk with protease inhibitors and management of the dyslipidemia. Am J Cardiol 2004;94(7):901-6.

Kris-Etherton P M, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106(21):2747-57.

Tousoulis D, Kampoli AM, Papageorgiou N, et al. Pathophysiology of atherosclerosis:the role of inflammation. Curr Pharm Des 2011;17(37):4089-110.

Li AC, Glass CK. The Macrophage foam cell as a target for therapeutic intervention. Nat Med 2002;8(11):1235-42.

Ohashi R, Mu H, Wang X, et al. Reverse cholesterol transport and cholesterol efflux in atherosclerosis. QJM 2005;98(12):845-56.

Wang N, Lan D, Chen W, et al. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004;101(26):9774-9.

Wang N, Silver DL, Costet P. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000;275(42):33053-8.

Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001;42(7):1007-17.

Higgins CF. ABC transporters:from microorganisms to man. Annu Rev Cell Biol 1992;8(1):67-113.

Davidson AL, Chen J. ATP-binding cassette transporters in bacteria. Annu Rev Biochem 2004;73:241-68.

Moody JE, Millen L, Binns D, et al. Cooperative ATPdependent association of the nucleotide binding cassettes during the catalytic cycle of ATP-binding cassette transporters. J Biol Chem 2002;277(24):21111-4.

Higgins CF, Linton KJ. The ATP switch model for ABC transporters. Nat Struct Mol Biol 2004;11(10):918-26.

Ye D, Hoekstra M, Out R, et al. Hepatic cell-specific ATPbinding cassette (ABC) transporter profiling identifies putative novel candidates for lipid homeostasis in mice. Atherosclerosis 2008;196(2):650-8.

Sanders TA, Lewis F, Slaughter S, et al. Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of alpha-linolenic acid, eicosapentaenoic and docosahexaenoic acid, or both on fibrinogen and clotting factors vii and xii in persons aged 45-70 y:The optilip study. Am J Clin Nutr 2006;84(3):513-22.

Ringseis RN, Schulz N, Saal D, et al. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMAdifferentiated THP-1 macrophages. J Nutr Biochem 2008;19(9):594-603.

Salehipour M, Javadi E, Zavvar Reza J, et al.Polyunsaturated fatty acids and modulation of cholesterol homeostasis in THP-1 macrophage-derived foam Cells. Int J Mol Sci 2010;11(11):4660-72.

Tiwari RL, Singh V, Barthwal MK. Macrophages:anelusive yet emerging therapeutic target of atherosclerosis. Med Res Rev 2008;28(4):483-544.

Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in colestrol efflux and immune responses. Arterioscler Thromb Vasc Biol 2010;30(2):139-43.

Croop JM, Tiller GE, Fletcher JA, et al. Isolation and characterization of a mammalian homolog of the Drosophila white gene. Gene 1997;185(1):77-85.

Chen H, Rossier C, Lalioti MD, et al. Cloning of the cDNA for a human homologue of the Drosophila white gene and mapping to chromosome 21q22.3. Am J Hum Genet 1996;59(1):66-75.

Savary S, Denizot F, Luciani M, et al. Molecular cloning of a mammalian ABC transporter homologous to Drosophila white gene. Mamm Genome 1996;7(9):673-6.

Walker JE, Saraste M, Runswick MJ, et al. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1982;1(8):945-51.

Dean M, Rzhetsky A, Allikmets R. The human ATPbinding cassette (ABC) transporter superfamily. Genome Res 2001;11(7):1156-66.

Klucken J, Büchler C, Orsó E, et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci U S A 2000;97(2):817-22.

Beyea MM, Heslop CL, Sawyez CG, et al. Selective upregulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S), 25-epoxycholesterol. J Biol Chem 2007;282(8):5207-16.

Ecker J, Langmann T, Moehle C, et al. Isomer specific effects of conjugated linoleic acid on macrophage ABCG1 transcription by a SREBP-1c dependent mechanism.Biochem Biophys Res Commun 2007;352(3):805-11.

Traves PG, Hortelano S, Zeini M, Chao TH, et al. Selective activation of liver X receptors by acanthoic acidrelated diterpenes. Mol Pharmacol 2007;71(6):1545-53.

Klopotek A, Hirche F, Eder K. PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2. Exp Biol Med (Maywood) 2006;231(8):1365-72.

Files
IssueVol 52, No 3 (2014) QRcode
SectionOriginal Article(s)
Keywords
Eicosapentaenoic Acid Atherosclerosis ABCG1 protein Real Time PCR

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Moradi Sarabi M, Doosti M, Einollahi N, Hesami SS, Dashti N. Effect of Eicosapentaenoic Acid on the Expression of ABCG1 Gene in the Human Monocyte THP-1 Cells. Acta Med Iran. 1;52(3):176-181.